Rhumatologie. Anti-TNF alpha: quels risques infectieux? Recommandations pratiques [Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations].
Details
Serval ID
serval:BIB_D6470C11F20E
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Rhumatologie. Anti-TNF alpha: quels risques infectieux? Recommandations pratiques [Rheumatology. TNF alpha-inhibitors: infection risks? Practical recommendations].
Journal
Revue Médicale Suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2011
Volume
7
Number
277
Pages
75-6, 78-9
Language
french
Notes
Publication types: English Abstract ; Journal Article ; Review
Abstract
Anti-TNF alpha are immunomodulatory treatments prescribed for some rheumatologic inflammatory diseases (ex: spondylarthropathy, rheumatoid polyarthritis). The randomised studies suggested that anti-TNF alpha therapy is associated with an overall risk of infectious diseases. The results of the observational studies are more reassuring. In this article, we will describe some results of theses studies and propose some practical recommendations in use of the anti-TNF alpha therapy.
Keywords
Antirheumatic Agents/adverse effects, Bacterial Infections/etiology, Bacterial Infections/prevention & control, Humans, Opportunistic Infections/etiology, Opportunistic Infections/prevention & control, Rheumatic Diseases/drug therapy, Tumor Necrosis Factor-alpha/antagonists & inhibitors
Pubmed
Create date
16/02/2012 14:40
Last modification date
20/08/2019 15:56
Usage data
